Literature DB >> 17460404

Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study.

Anabelle Brocard1, Anne-Chantal Knol, Amir Khammari, Brigitte Dréno.   

Abstract

BACKGROUND: Hidradenitis suppurativa (Verneuil's disease) is a chronic suppurative dermatosis involving apocrine glands with a severe impact on the quality of life, which is enhanced by the fact that the drugs usually prescribed are poorly effective.
OBJECTIVE: We discuss a new therapeutic approach based on zinc salts.
METHODS: We performed a pilot study on 22 patients, mainly from grade I or II in Hurley's classification. All included patients had previously been prescribed a treatment (antibiotic, isotretinoin, surgery or anti-androgens), which was inefficient. They were then treated with 90 mg of zinc gluconate per day (15 mg zinc per Rubozinc capsule).
RESULTS: We observed a clinical response in all patients, with 8 complete remissions (CR) and 14 partial remissions (PR). When CR was obtained, the treatment was progressively decreased (average of 3.5 capsules/day); 4/22 patients experienced side-effects, mainly gastro-intestinal.
CONCLUSION: Zinc salts could provide a new therapeutic alternative for the treatment of hidradenitis suppurativa. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460404     DOI: 10.1159/000100883

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  11 in total

1.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

2.  [Acne inversa].

Authors:  F G Bechara; W Hartschuh
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

Review 3.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

Review 4.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

Review 5.  [Drug therapy of acne inversa].

Authors:  S Schneider-Burrus; E Arpa; C Kors; T Stavermann; R Sabat; G Kokolakis
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

Review 6.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 7.  Zinc therapy in dermatology: a review.

Authors:  Mrinal Gupta; Vikram K Mahajan; Karaninder S Mehta; Pushpinder S Chauhan
Journal:  Dermatol Res Pract       Date:  2014-07-10

Review 8.  Update on hidradenitis suppurativa: connecting the tracts.

Authors:  Liza Gill; Melissa Williams; Iltefat Hamzavi
Journal:  F1000Prime Rep       Date:  2014-12-01

9.  Evaluation of zinc sulfate mucoadhesive formulation on recurrent aphthous stomatitis: a randomized double-blind, placebo-controlled clinical trial.

Authors:  Anahita Ghorbani; Jafar Akbari; Maryam Boorboor; Zahra Nekoukar; Gohar Eslami
Journal:  BMC Oral Health       Date:  2020-07-28       Impact factor: 2.757

Review 10.  Hidradenitis Suppurativa: Inside and Out.

Authors:  Sharmila Patil; Astuty Apurwa; Nitin Nadkarni; Shweta Agarwal; Parag Chaudhari; Manjyot Gautam
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.